United Therapeutics (UTHR) Goodwill & Intangibles (2010 - 2026)

United Therapeutics has disclosed Goodwill & Intangibles across 17 years of filings, most recently posting $115.5 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $115.5 million, up 3.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $115.5 million (up 3.4% YoY), and the FY2025 annual result was $116.5 million, up 4.11% from the prior year.
• Goodwill & Intangibles came in at $115.5 million for Q1 2026 at United Therapeutics, down from $116.5 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $116.7 million in Q3 2025 to a low of $44.4 million in Q3 2023.
• The 5-year median for Goodwill & Intangibles is $111.7 million (2025), against an average of $85.4 million.
• Across the five-year window, Goodwill & Intangibles surged 159.33% in 2024 and dropped 3.21% in 2025, its largest moves.
• United Therapeutics' Goodwill & Intangibles stood at $44.5 million in 2022, then jumped by 156.63% to $114.2 million in 2023, then decreased by 2.01% to $111.9 million in 2024, then increased by 4.11% to $116.5 million in 2025, then retreated by 0.86% to $115.5 million in 2026.
• The last three Goodwill & Intangibles figures came in at $115.5 million (Q1 2026), $116.5 million (Q4 2025), and $116.7 million (Q3 2025), per Business Quant data.